Beijing Chunlizhengda Medical Instruments Co., Ltd. Class A

As of December 31, 2025, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H carries a market capitalization of 12.05B, placing it among publicly traded companies globally. Its enterprise value stands at 9.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H's next confirmed earnings release is scheduled for October 30, 2026.

As of December 31, 2025, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 810.79M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H maintains a current ratio of 5.20, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H's stock has declined approximately 58.04% over the past 52 weeks. The 50-day moving average sits at 7.96, while the 200-day moving average is 10.72.

As of December 31, 2025, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H holds 2.47B in cash and equivalents against 3.64M in total debt, resulting in a net debt position of -1.57B. Total book value stands at 3.32B, with working capital of 2.71B providing operational flexibility.

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H's most recent stock split took place on April 20, 2020 with a 2:5 split ratio.